Mark Kroll

(Dr. Mark Kroll Ph.D.)

Currently holds positions in Axon Enterprise Inc and Haemonetics Corp

Positions

Position Company Period
Director Axon Enterprise Inc Jan. 22, 2003 -
Independent Director Haemonetics Corp Jan. 1, 2006 -
Mark Kroll's trades of Axon Enterprise Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-03-08 2023-03-07 S Sale
3,457 -25.4%
220.72
USD 763,043
3,457 -25.4% 220.72 USD 763,043
2023-03-08 2023-03-07 S Sale
92 -0.7%
220.85
USD 20,318
92 -0.7% 220.85 USD 20,318
2022-08-16 2022-08-15 S Sale
8,016 -33.1%
73.71
USD 590,859
8,016 -33.1% 73.71 USD 590,859
2022-06-09 2022-06-08 S Sale
3,159 -18.7%
102.82
USD 324,796
3,159 -18.7% 102.82 USD 324,796
2021-05-28 2021-05-26 S Sale
11,813 -39.0%
55.10
USD 650,896
11,813 -39.0% 55.10 USD 650,896
2021-05-14 2021-05-12 S Sale
4,204 -23.9%
124.94
USD 525,260
4,204 -23.9% 124.94 USD 525,260
2020-11-17 2020-11-16 S Sale
2,993 -13.9%
120.44
USD 360,477
2,993 -13.9% 120.44 USD 360,477
2020-04-13 2020-04-09 PS Planned sale
4,329 -19.0%
102.00
USD 441,558
4,329 -19.0% 102.00 USD 441,558
2020-04-13 2020-04-09 PS Planned sale
6,573 -22.4%
102.00
USD 670,446
6,573 -22.4% 102.00 USD 670,446
2019-11-14 2019-11-13 S Sale
4,168 -17.6%
64.30
USD 267,987
4,168 -17.6% 64.30 USD 267,987
// ... existing code ... // ... rest of the file ...